HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Histological classification of nesidioblastosis: efficacy of immunohistochemical study of neuron-specific enolase.

Abstract
Pancreatic specimens of six patients with nesidioblastosis were studied by light microscopy and immunohistochemistry in order to classify the changes of the endocrine pancreas and relate them to the clinical outcome. Neuron-specific enolase immunostaining was useful in demonstrating the distribution of whole pancreatic endocrine cells. The six cases with nesidioblastosis were classified into two types; four cases of focal type (head 1, body 1, tail 2), and two cases of diffuse type. The histological classification show a correlation to the clinical outcome. The patients with a focal body or tail type showed normal blood sugar levels immediately after operation. On the other hand the patients with both diffuse type and a focal head type needed medical treatment within a few months after operation. Therefore, these cases should be followed with great care postoperatively. A partial 80% to 90% pancreatectomy might be sufficient for each type except for the focal head type. When the intraoperative examination (both macroscopic and microscopic) is suggestive of focal head type, a pancreatectomy of 95% or more is called for.
AuthorsT Taguchi, S Suita, R Hirose
JournalJournal of pediatric surgery (J Pediatr Surg) Vol. 26 Issue 7 Pg. 770-4 (Jul 1991) ISSN: 0022-3468 [Print] United States
PMID1895184 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Phosphopyruvate Hydratase
Topics
  • Cell Count
  • Female
  • Humans
  • Immunohistochemistry
  • Infant
  • Intraoperative Care
  • Islets of Langerhans (enzymology, pathology, surgery)
  • Male
  • Pancreatectomy (methods)
  • Pancreatic Diseases (classification, enzymology, pathology, surgery)
  • Phosphopyruvate Hydratase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: